DK484685A - Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse - Google Patents

Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse Download PDF

Info

Publication number
DK484685A
DK484685A DK484685A DK484685A DK484685A DK 484685 A DK484685 A DK 484685A DK 484685 A DK484685 A DK 484685A DK 484685 A DK484685 A DK 484685A DK 484685 A DK484685 A DK 484685A
Authority
DK
Denmark
Prior art keywords
compositions
micellular
tumors
human
target
Prior art date
Application number
DK484685A
Other languages
English (en)
Other versions
DK167907B1 (da
DK484685D0 (da
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Original Assignee
Vestar Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Research Inc filed Critical Vestar Research Inc
Publication of DK484685D0 publication Critical patent/DK484685D0/da
Publication of DK484685A publication Critical patent/DK484685A/da
Application granted granted Critical
Publication of DK167907B1 publication Critical patent/DK167907B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK484685A 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker DK167907B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67420184A 1984-11-23 1984-11-23
US67420184 1984-11-23

Publications (3)

Publication Number Publication Date
DK484685D0 DK484685D0 (da) 1985-10-22
DK484685A true DK484685A (da) 1986-05-24
DK167907B1 DK167907B1 (da) 1994-01-03

Family

ID=24705713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484685A DK167907B1 (da) 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker

Country Status (8)

Country Link
EP (1) EP0182131B1 (da)
JP (1) JPS61158933A (da)
KR (1) KR860004315A (da)
AT (1) ATE70456T1 (da)
CA (1) CA1267840A (da)
DE (1) DE3584948D1 (da)
DK (1) DK167907B1 (da)
IE (1) IE58124B1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710371A1 (de) * 1987-03-28 1988-10-13 Dornier Medizintechnik Zerstoerung von krankhaft veraenderten gewebezellen
JPH09504797A (ja) * 1993-11-08 1997-05-13 ペプチド デリバリー システムズ プロプリエタリイ リミテッド ラベルされた診断用組成物と，その使用方法
ATE281886T1 (de) * 1994-01-21 2004-11-15 Sirtex Medical Ltd Yttria partikelförmiges gut
US6537518B1 (en) 1994-01-21 2003-03-25 Sirtex Medical Limited Particulate material
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances

Also Published As

Publication number Publication date
EP0182131B1 (en) 1991-12-18
ATE70456T1 (de) 1992-01-15
KR860004315A (ko) 1986-06-20
JPH0582369B2 (da) 1993-11-18
EP0182131A1 (en) 1986-05-28
DK167907B1 (da) 1994-01-03
DK484685D0 (da) 1985-10-22
DE3584948D1 (de) 1992-01-30
IE852601L (en) 1986-05-23
IE58124B1 (en) 1993-07-14
JPS61158933A (ja) 1986-07-18
CA1267840A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
AU5418486A (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
AU572815B2 (en) Pharmaceutical calcitonin compositions for intranasal application
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
IT8320435A0 (it) Composizione per il trattamento dell'acne.
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
DK484685D0 (da) Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
ITRM910730A0 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" diradicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali
SE8107181L (sv) Dental komposition
DK484585D0 (da) Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse
IT8547799A0 (it) Procedimento per la lavorazione fine dei fianchi di ruote dentate con utensili rivestiti di granuli di materiali duri e procedimento per l'affilatura degli utensili
DE3563047D1 (en) Bis(4-isocyanatophenoxy) alkanes optionally methyl-substituted in position 3, method for their preparation and their use in the preparation of polyurethanes
IT1208798B (it) Procedimento per la produzione din 4 3 amminopropil amminobutil 2 2diidrossi etanammide e suo impiegocome intermedio nella sintesi dicomposti antitumorali
ZA857721B (en) Process for treatment of rheumatic diseases
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
IT1175920B (it) Impiego di 1,4-diidropiridine in prodotti antiarteriolerosi e loro preparazione
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
FR2658810B1 (fr) Composition contenant des oligo-elements et procedes mettant en óoeuvre cette composition.
EP0572549A4 (da)
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
ATE87314T1 (de) Platin-arzneimittel.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired